(IN BRIEF) Sanofi has completed the sale of a 50.0% controlling stake in its consumer healthcare division, Opella, to CD&R, creating a global leader in consumer healthcare. Sanofi retains a significant 48.2% stake, while Bpifrance will hold 1.8% and join … Read the full press release →
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Allegra, biopharma, Bpifrance, CD&R expertise, CDR, consumer health, Consumer HealthCare, Doliprane, Dulcolax, Eric Rouzier, global leader, Healthcare Innovation, healthcare transformation, Julie Van Ongevalle, Opella, OTC, partnership, Paul Hudson, Sanofi, sustainable growth, VMS